Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

Comcast Ventures and BDMI are set to record profitable exits through the deal, showing the new models of digital media can still make for inviting investments.

Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.

Data software provider Weka raised $73m in a round led by Hitachi Ventures while Advance Publications exited social impact technology developer EverFi in a $750m acquisition.

Data storage technology producer Dera pulled in over $150m through a China Unicom-backed series C round while GlobalBees raised in excess of $110m in a round featuring SoftBank and FirstCry.

Drug development platform creator Xbiome has raised nearly $100m in series B funding while bioindustrial startup services provider 21st.Bio secured a similar amount from Novo.

Mobile wallet developer Momo grabbed $200m in a Mizuho Bank-led round valuing it above $2bn while silicon wafer producer Mieke pulled in $188m.

China-based chipmakers Chipone Technology and Vastai Technologies raised a total of over $1.2bn while Reddit has confidentially filed to go public.

GMG Ventures and Hearst Ventures have returned to back the data analytics service, joining financial investors such as Abrdn, which had hitherto concentrated on other asset classes.